Metropolitan Life Insurance Company (MetLife)’s American Renal Associates Holdings, Inc ARA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ARA Stock Details ARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,774	Closed	-$44.8K	–	2625
2020 Q1	$44.8K	Buy	+6,774	New	+$59K	﹤0.01%	2395
2018 Q4	–	Sell	-4,918	Closed	-$106K	–	2593
2018 Q3	$106K	Buy	+4,918	New	+$93.1K	﹤0.01%	2416

Other funds holding ARA

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Whitegate Investment Counselors Concord, New Hampshire $351M AUM 16.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ARA Position: Q2 2020 in Review

Metropolitan Life Insurance Company (MetLife) sold out of American Renal Associates Holdings, Inc (ARA) in Q2 2020, closing a stake of 6,774 shares — an estimated $44.8K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ARA in Q3 2018 and held it in 2 quarters. The position peaked at $106K in Q3 2018. 56 funds tracked by Wall St. Rank hold ARA as of Q2 2020.

Metropolitan Life Insurance Company (MetLife) reported no remaining American Renal Associates Holdings, Inc position as of Q2 2020 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 6,774 American Renal Associates Holdings, Inc shares in Q2 2020, an estimated $44.8K.
Metropolitan Life Insurance Company (MetLife) first reported a position in American Renal Associates Holdings, Inc in Q3 2018 and held it in 2 quarters.
Metropolitan Life Insurance Company (MetLife)'s American Renal Associates Holdings, Inc position peaked at $106K in Q3 2018.
56 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q2 2020.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2020, filed 14 Aug 2020.